Sagent Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT PHARMS INC
SAGENT PHARMS INC has fifty-five approved drugs.
Summary for Sagent Pharms Inc
| US Patents: | 0 |
| Tradenames: | 47 |
| Ingredients: | 46 |
| NDAs: | 55 |
Drugs and US Patents for Sagent Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms Inc | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 078274-002 | Dec 29, 2008 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sagent Pharms Inc | KETOROLAC TROMETHAMINE | ketorolac tromethamine | INJECTABLE;INJECTION | 091065-001 | Nov 27, 2013 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sagent Pharms Inc | CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 202462-001 | May 29, 2015 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
